Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Debt Ratio (2016 - 2025)

Haemonetics has reported Debt Ratio over the past 16 years, most recently at 0.49 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.49 for Q4 2025, up 1.61% from a year ago — trailing twelve months through Dec 2025 was 0.49 (up 1.61% YoY), and the annual figure for FY2025 was 0.5, up 35.82%.
  • Debt Ratio for Q4 2025 was 0.49 at Haemonetics, down from 0.5 in the prior quarter.
  • Over the last five years, Debt Ratio for HAE hit a ceiling of 0.5 in Q3 2025 and a floor of 0.37 in Q1 2024.
  • Median Debt Ratio over the past 5 years was 0.43 (2022), compared with a mean of 0.44.
  • Biggest five-year swings in Debt Ratio: skyrocketed 80.57% in 2022 and later decreased 13.56% in 2023.
  • Haemonetics' Debt Ratio stood at 0.43 in 2021, then decreased by 5.8% to 0.41 in 2022, then fell by 3.09% to 0.4 in 2023, then increased by 22.3% to 0.48 in 2024, then grew by 1.61% to 0.49 in 2025.
  • The last three reported values for Debt Ratio were 0.49 (Q4 2025), 0.5 (Q3 2025), and 0.5 (Q2 2025) per Business Quant data.